Eurofins BioPharma Product Testing offers a broad spectrum genetic and alternative toxicology models to evaluate the safety or the pharmacological efficacy of a drug.
With more than 30 years of experience and state-of-the-art equipment, we deliver project specific solutions in the fields of genetic and alternative toxicology. We provide full nonclinical development programs in support of IND and later-stage regulatory submissions for new chemical (NCE) or biological entities (NBE).
As a leader in safety testing, Eurofins BioPharma Product Testing is committed to the advancement of animal welfare and concern for animals as a core aspect of corporate social responsibility. We also offer several methods to replace the use of in vivo methods to evaluate eye irritancy, local tolerance, performance testing and others.
Our toxicology offering includes: